Stem cell transplantation in Europe: Trends and prospects
Abstract The aim of the present study was to identify trends in numbers of European patients treated with autologous and allogeneic haematopoietic stem cell transplantation (HSCT) as well as to provide anticipated transplant rates for the upcoming years. The following indications were considered: ha...
Gespeichert in:
| Veröffentlicht in: | European journal of cancer (1990) 2007-11, Vol.43 (16), p.2359-2365 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2365 |
|---|---|
| container_issue | 16 |
| container_start_page | 2359 |
| container_title | European journal of cancer (1990) |
| container_volume | 43 |
| creator | Tan, S.S Uyl-de Groot, C.A Huijgens, P.C Fibbe, W.E |
| description | Abstract The aim of the present study was to identify trends in numbers of European patients treated with autologous and allogeneic haematopoietic stem cell transplantation (HSCT) as well as to provide anticipated transplant rates for the upcoming years. The following indications were considered: haematological malignancies (acute leukaemias, myeloproliferative disorders, lymphoproliferative disorders and multiple myeloma), solid tumours and non-malignant diseases. Numbers of patients treated from 1990 to 2004 were extracted from the European Group for Blood and Marrow Transplantation database, extrapolated to 2012 using mathematic models and adjusted to the literature study and expert opinion. In Europe, a 13% raise in HSCT utilisation is to be expected from 2005 to 2010, mostly due to the growing application of reduced-intensity conditioning regimens followed by allogeneic HSCT. Growing transplant rates are likely to exert health expenditure budgets and put pressure on health care providers and health insurers in Europe. Therefore, the rapid expansion would ideally imply a simultaneous increase in HSCT budgets. |
| doi_str_mv | 10.1016/j.ejca.2007.08.020 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68447304</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0959804907006910</els_id><sourcerecordid>68447304</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-677e9fe1e15abaeaffe3a0f2dbbfb0eafac7697616bb5ce66f2d7258b0b7ee3d3</originalsourceid><addsrcrecordid>eNp9kU1r3DAQhkVISTbb_IEcii_Jze7IH_ooJRBCmgQWekh6FpI8Brle2ZXsQP59ZXYh0ENPYtAzMy_PEHJFoaBA2de-wN7qogTgBYgCSjghGyq4zEE05SnZgGxkLqCW5-Qixh4SKGo4I-eUSyolwIbIlxn3mcVhyOagfZwG7Wc9u9FnzmcPSxgn_Ja9BvRtzLRvsymMcUI7x8_kU6eHiJfHd0t-_Xh4vX_Kdz8fn-_vdrmtKznnjHOUHVKkjTYadddhpaErW2M6A6nWljPJGWXGNBYZS1-8bIQBwxGrttqSm8PctPnPgnFWexfXwNrjuETFRF3zCuoElgfQpogxYKem4PY6vCsKahWmerUKU6swBUIlYanpy3H6YvbYfrQcDSXg-gjoaPXQJUnWxQ9OMkHret3-_cBhcvHmMKhoHXqLrQtJl2pH9_8ct_-028F5lzb-xneM_bgEnywrqmKpQL2sp10vCxyASQrVX4RLnw8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68447304</pqid></control><display><type>article</type><title>Stem cell transplantation in Europe: Trends and prospects</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Tan, S.S ; Uyl-de Groot, C.A ; Huijgens, P.C ; Fibbe, W.E</creator><creatorcontrib>Tan, S.S ; Uyl-de Groot, C.A ; Huijgens, P.C ; Fibbe, W.E</creatorcontrib><description>Abstract The aim of the present study was to identify trends in numbers of European patients treated with autologous and allogeneic haematopoietic stem cell transplantation (HSCT) as well as to provide anticipated transplant rates for the upcoming years. The following indications were considered: haematological malignancies (acute leukaemias, myeloproliferative disorders, lymphoproliferative disorders and multiple myeloma), solid tumours and non-malignant diseases. Numbers of patients treated from 1990 to 2004 were extracted from the European Group for Blood and Marrow Transplantation database, extrapolated to 2012 using mathematic models and adjusted to the literature study and expert opinion. In Europe, a 13% raise in HSCT utilisation is to be expected from 2005 to 2010, mostly due to the growing application of reduced-intensity conditioning regimens followed by allogeneic HSCT. Growing transplant rates are likely to exert health expenditure budgets and put pressure on health care providers and health insurers in Europe. Therefore, the rapid expansion would ideally imply a simultaneous increase in HSCT budgets.</description><identifier>ISSN: 0959-8049</identifier><identifier>EISSN: 1879-0852</identifier><identifier>DOI: 10.1016/j.ejca.2007.08.020</identifier><identifier>PMID: 17919900</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Biological and medical sciences ; Europe - epidemiology ; Female ; Haematopoietic stem cell transplantation ; Hematologic Diseases - epidemiology ; Hematologic Diseases - therapy ; Hematology, Oncology and Palliative Medicine ; Hematopoietic Stem Cell Transplantation - statistics & numerical data ; Hematopoietic Stem Cell Transplantation - trends ; Humans ; Male ; Medical sciences ; Oncology ; Pharmacology. Drug treatments ; Scenario analysis ; Transplant rates ; Tumors</subject><ispartof>European journal of cancer (1990), 2007-11, Vol.43 (16), p.2359-2365</ispartof><rights>Elsevier Ltd</rights><rights>2007 Elsevier Ltd</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-677e9fe1e15abaeaffe3a0f2dbbfb0eafac7697616bb5ce66f2d7258b0b7ee3d3</citedby><cites>FETCH-LOGICAL-c439t-677e9fe1e15abaeaffe3a0f2dbbfb0eafac7697616bb5ce66f2d7258b0b7ee3d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejca.2007.08.020$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19681444$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17919900$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tan, S.S</creatorcontrib><creatorcontrib>Uyl-de Groot, C.A</creatorcontrib><creatorcontrib>Huijgens, P.C</creatorcontrib><creatorcontrib>Fibbe, W.E</creatorcontrib><title>Stem cell transplantation in Europe: Trends and prospects</title><title>European journal of cancer (1990)</title><addtitle>Eur J Cancer</addtitle><description>Abstract The aim of the present study was to identify trends in numbers of European patients treated with autologous and allogeneic haematopoietic stem cell transplantation (HSCT) as well as to provide anticipated transplant rates for the upcoming years. The following indications were considered: haematological malignancies (acute leukaemias, myeloproliferative disorders, lymphoproliferative disorders and multiple myeloma), solid tumours and non-malignant diseases. Numbers of patients treated from 1990 to 2004 were extracted from the European Group for Blood and Marrow Transplantation database, extrapolated to 2012 using mathematic models and adjusted to the literature study and expert opinion. In Europe, a 13% raise in HSCT utilisation is to be expected from 2005 to 2010, mostly due to the growing application of reduced-intensity conditioning regimens followed by allogeneic HSCT. Growing transplant rates are likely to exert health expenditure budgets and put pressure on health care providers and health insurers in Europe. Therefore, the rapid expansion would ideally imply a simultaneous increase in HSCT budgets.</description><subject>Biological and medical sciences</subject><subject>Europe - epidemiology</subject><subject>Female</subject><subject>Haematopoietic stem cell transplantation</subject><subject>Hematologic Diseases - epidemiology</subject><subject>Hematologic Diseases - therapy</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Hematopoietic Stem Cell Transplantation - statistics & numerical data</subject><subject>Hematopoietic Stem Cell Transplantation - trends</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Oncology</subject><subject>Pharmacology. Drug treatments</subject><subject>Scenario analysis</subject><subject>Transplant rates</subject><subject>Tumors</subject><issn>0959-8049</issn><issn>1879-0852</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1r3DAQhkVISTbb_IEcii_Jze7IH_ooJRBCmgQWekh6FpI8Brle2ZXsQP59ZXYh0ENPYtAzMy_PEHJFoaBA2de-wN7qogTgBYgCSjghGyq4zEE05SnZgGxkLqCW5-Qixh4SKGo4I-eUSyolwIbIlxn3mcVhyOagfZwG7Wc9u9FnzmcPSxgn_Ja9BvRtzLRvsymMcUI7x8_kU6eHiJfHd0t-_Xh4vX_Kdz8fn-_vdrmtKznnjHOUHVKkjTYadddhpaErW2M6A6nWljPJGWXGNBYZS1-8bIQBwxGrttqSm8PctPnPgnFWexfXwNrjuETFRF3zCuoElgfQpogxYKem4PY6vCsKahWmerUKU6swBUIlYanpy3H6YvbYfrQcDSXg-gjoaPXQJUnWxQ9OMkHret3-_cBhcvHmMKhoHXqLrQtJl2pH9_8ct_-028F5lzb-xneM_bgEnywrqmKpQL2sp10vCxyASQrVX4RLnw8</recordid><startdate>20071101</startdate><enddate>20071101</enddate><creator>Tan, S.S</creator><creator>Uyl-de Groot, C.A</creator><creator>Huijgens, P.C</creator><creator>Fibbe, W.E</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20071101</creationdate><title>Stem cell transplantation in Europe: Trends and prospects</title><author>Tan, S.S ; Uyl-de Groot, C.A ; Huijgens, P.C ; Fibbe, W.E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-677e9fe1e15abaeaffe3a0f2dbbfb0eafac7697616bb5ce66f2d7258b0b7ee3d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Biological and medical sciences</topic><topic>Europe - epidemiology</topic><topic>Female</topic><topic>Haematopoietic stem cell transplantation</topic><topic>Hematologic Diseases - epidemiology</topic><topic>Hematologic Diseases - therapy</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Hematopoietic Stem Cell Transplantation - statistics & numerical data</topic><topic>Hematopoietic Stem Cell Transplantation - trends</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Oncology</topic><topic>Pharmacology. Drug treatments</topic><topic>Scenario analysis</topic><topic>Transplant rates</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tan, S.S</creatorcontrib><creatorcontrib>Uyl-de Groot, C.A</creatorcontrib><creatorcontrib>Huijgens, P.C</creatorcontrib><creatorcontrib>Fibbe, W.E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cancer (1990)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tan, S.S</au><au>Uyl-de Groot, C.A</au><au>Huijgens, P.C</au><au>Fibbe, W.E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stem cell transplantation in Europe: Trends and prospects</atitle><jtitle>European journal of cancer (1990)</jtitle><addtitle>Eur J Cancer</addtitle><date>2007-11-01</date><risdate>2007</risdate><volume>43</volume><issue>16</issue><spage>2359</spage><epage>2365</epage><pages>2359-2365</pages><issn>0959-8049</issn><eissn>1879-0852</eissn><abstract>Abstract The aim of the present study was to identify trends in numbers of European patients treated with autologous and allogeneic haematopoietic stem cell transplantation (HSCT) as well as to provide anticipated transplant rates for the upcoming years. The following indications were considered: haematological malignancies (acute leukaemias, myeloproliferative disorders, lymphoproliferative disorders and multiple myeloma), solid tumours and non-malignant diseases. Numbers of patients treated from 1990 to 2004 were extracted from the European Group for Blood and Marrow Transplantation database, extrapolated to 2012 using mathematic models and adjusted to the literature study and expert opinion. In Europe, a 13% raise in HSCT utilisation is to be expected from 2005 to 2010, mostly due to the growing application of reduced-intensity conditioning regimens followed by allogeneic HSCT. Growing transplant rates are likely to exert health expenditure budgets and put pressure on health care providers and health insurers in Europe. Therefore, the rapid expansion would ideally imply a simultaneous increase in HSCT budgets.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>17919900</pmid><doi>10.1016/j.ejca.2007.08.020</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0959-8049 |
| ispartof | European journal of cancer (1990), 2007-11, Vol.43 (16), p.2359-2365 |
| issn | 0959-8049 1879-0852 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68447304 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Biological and medical sciences Europe - epidemiology Female Haematopoietic stem cell transplantation Hematologic Diseases - epidemiology Hematologic Diseases - therapy Hematology, Oncology and Palliative Medicine Hematopoietic Stem Cell Transplantation - statistics & numerical data Hematopoietic Stem Cell Transplantation - trends Humans Male Medical sciences Oncology Pharmacology. Drug treatments Scenario analysis Transplant rates Tumors |
| title | Stem cell transplantation in Europe: Trends and prospects |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T17%3A42%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stem%20cell%20transplantation%20in%20Europe:%20Trends%20and%20prospects&rft.jtitle=European%20journal%20of%20cancer%20(1990)&rft.au=Tan,%20S.S&rft.date=2007-11-01&rft.volume=43&rft.issue=16&rft.spage=2359&rft.epage=2365&rft.pages=2359-2365&rft.issn=0959-8049&rft.eissn=1879-0852&rft_id=info:doi/10.1016/j.ejca.2007.08.020&rft_dat=%3Cproquest_cross%3E68447304%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68447304&rft_id=info:pmid/17919900&rft_els_id=S0959804907006910&rfr_iscdi=true |